Changes in treatment patterns and their influence on long-term survival in patients with stages I-III gastric cancer in the Netherlands

International Journal of Cancer

Volumn 133, Issue 8, 2013, Pages 1859-1866

  Dassen, A E ^a   Dikken, J L ^b,c   Van De Velde, C J H ^b   Wouters, M W J M ^b,c   Bosscha, K ^a   Lemmens, V E P P ^d,e  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^d The Netherlands   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

gastric cancer; postoperative mortality; survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; STOMACH CANCER; STOMACH SURGERY; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME;

GASTRIC CANCER; POSTOPERATIVE MORTALITY; SURVIVAL;

AGED; CARDIA; CHEMOTHERAPY, ADJUVANT; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NETHERLANDS; PERIOPERATIVE CARE; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84881551482     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28192     Document Type: Article

References (23)

1. Dassen AE, Lemmens VE, van de Poll-Franse LV, et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer 2010; 46: 1101-10.
2. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45: 931-91.
3. Lepage C, Sant M, Verdecchia A, et al. Operative mortality after gastric cancer resection and long-term survival differences across Europe. Br J Surg 2010; 97: 235-9.
4. Damhuis RA, Meurs CJ, Dijkhuis CM, et al. Hospital volume and post-operative mortality after resection for gastric cancer. Eur J Surg Oncol 2002; 28: 401-5.
5. Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11: 439-49.
6. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
7. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-30.
8. Dikken JL, Jansen EP, Cats A, et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol 2010; 28: 2430-6.
9. Dikken JL, Jansen EP, Cats A, et al. Reply to F. Sclafani et al. J Clin Oncol 2010; 28: e617-8.
10. Schouten LJ, Hoppener P, van den Brandt PA, et al. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 1993; 22: 369-76.
11. Allum WH, Griffin SM, Watson A, et al. Guidelines for the management of oesophageal and gastric cancer. Gut 2002; 50 (Suppl 5): v1-23.
12. Allum WH, Blazeby JM, Griffin SM, et al. Guidelines for the management of oesophageal and gastric cancer. Gut 2011; 60: 1449-72.
13. Dassen AE, Lips DJ, Hoekstra CJ, et al. FDG-PET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol 2009; 35: 449-55.
14. Chen CY, Hsu JS, Wu DC, et al. Gastric cancer: preoperative local staging with 3D multi-detector row CT - correlation with surgical and histopathologic results. Radiology 2007; 242: 472-82.
15. Puli SR, Batapati Krishna Reddy J, Bechtold ML, et al. How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-Analysis and systematic review. World J Gastroenterol 2008; 14: 4011-9.
16. Msika S, Benhamiche AM, Tazi MA, et al. Improvement of operative mortality after curative resection for gastric cancer: population-based study. World J Surg 2000; 24: 1137-42.
17. Dikken JL, Lemmens VE, Wouters MW, et al. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer 2012; 48: 1624-32.
18. Bouvier AM, Sant M, Verdecchia A, et al. What reasons lie behind long-term survival differences for gastric cancer within Europe? Eur J Cancer 2010; 46: 1086-92.
19. Lemmens VE, Dassen AE, van der Wurff AA, et al. Lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio. Eur J Surg Oncol 2011; 37: 488-96.
20. Siewert JR, Stein HJ,. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-9.
21. Sobin LH, Compton CC,. TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 2010; 116: 5336-9.
22. Dikken JL, van Grieken NC, Krijnen P, et al. Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. Eur J Surg Oncol 2012; 38: 319-25.
23. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011; 14: 101-12.